iProXProteomicsMianmian LiaoHomo Sapienshttp://www.iprox.org/page/project.html?id=IPX0016372000lmmcsq@163.comThe Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical UniversityiProXfalseCompound Phyllanthus urinaria L. combined with lenvatinib inhibits the proliferation of HepG2 cells by blocking the PI3K-Akt and complement and coagulation cascade pathwaysThe combination of CP and lenvatinib effectively inhibits the proliferation, cloning, migration, and invasion of HepG2 liver cancer cells. This effect is related to the regulation of the PI3K/Akt and complement and coagulation cascade pathways. This study highlights the potential of CP and lenvatinib combination therapy for the treatment of advanced liver cancer.Wed Apr 22 00:00:00 BST 2026PXD0774719606